Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Mol Oncol. 2013 Jan 19;7(3):555–566. doi: 10.1016/j.molonc.2013.01.003

Table 2.

Correlation of LSD1, cyclinA1, VEGF and clinical parameters

A. Correlation coefficients between LSD1, cyclinA1 and VEGF-A in prostate cancer specimens. Correlation between LSD1, VEGF-A and cyclinA1 expression in tissue specimens from patients with prostate cancer were determined using the Spearman rank correlation test. Spearman correlation coefficient and p values are shown for each correlation.
Index LSD1 P value cyclinA1 P value VEGF-A P value
LSD1 - - −0.067 ns 0.315 0.019
cyclinA1 −0.067 ns - - 0.287 0.033
VEGF-A 0.315 0.019 0.287 0.033 - -
B. Correlation of LSD1 and JMJD2A with clinical parameters in PCa patients
LSD1 JMJD2A
Low High P value Low High P Value
Patients (%) 7 (12 %) 52 (88 %) 37 (63 %) 22 (37 %)
* Age 63.2 (12 %) 62.5 (88 %) 0.78 63.1 (62 %) 61.6 (38 %) 0.36
* PSA 9.6 (14 %) 8.5 (86 %) 0.59 9.5 (64 %) 7.3 (36 %) 0.11
* BCR 58.4 (12 %) 30.9 (88 %) 0.01 32.8 (63 %) 36.3 (37 %) 0.65
* Survival 65.0 (12 %) 48.4 (88 %) 0.21 52.8 (63 %) 46.2 (37 %) 0.45
*

mean values are presented. Time to biochemical recurrence and survival is indicated in months. Statistically significant associations are indicated in grey. PSA: prostate specific antigen; BCR: biochemical recurrence